Roger Jeffs
Chief Executive Officer bei LIQUIDIA CORPORATION
Vermögen: 49 Mio $ am 31.03.2024
Profil
Roger A.
Jeffs is the founder of Kriya Therapeutics, Inc. (founded in 2019) where he holds the title of Vice Chairman.
He is also the founder of Bull City Select Investments LLC.
Dr. Jeffs's current job(s) include being the Chief Executive Officer & Director at Liquidia Corp.
since 2020, the Lead Independent Director at Axsome Therapeutics, Inc. since 2014, and a Director at Albireo AB.
Dr. Jeffs's former job(s) include being the President, Co-Chief Executive Officer & Director at United Therapeutics Corp.
from 1998 to 2016, an Associate Director-Clinical Research at Amgen, Inc. from 1995 to 1998, an Independent Director at Sangamo Therapeutics, Inc. from 2017 to 2019, an Independent Director at Spyryx Biosciences, Inc., a Director at Sio Gene Therapies, Inc. from 2018 to 2019, an Independent Director at Dova Pharmaceuticals, Inc. from 2017 to 2019, an Independent Director at Albireo Pharma, Inc. from 2017 to 2022, a Director at Roivant Sciences, Inc. from 2018 to 2019, a Director at Evecxia, Inc. from 2016 to 2021, a Director at RareGen LLC from 2018 to 2020, and a Member-Clinical Research at Glaxo Wellcome, Inc. from 1993 to 1995.
Dr. Jeffs's education history includes an undergraduate degree from Duke University in 1984 and a doctorate degree from UNC School of Medicine in 1991.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LIQUIDIA CORPORATION
3,18% | 12.04.2024 | 2 415 247 ( 3,18% ) | 36 Mio $ | 31.03.2024 |
| 15.03.2024 | 167 668 ( 0,35% ) | 13 Mio $ | 31.03.2024 |
Aktive Positionen von Roger Jeffs
| Unternehmen | Position | Beginn |
|---|---|---|
| AXSOME THERAPEUTICS, INC. | Director/Board Member | 01.12.2014 |
| LIQUIDIA CORPORATION | Chief Executive Officer | 03.01.2022 |
Kriya Therapeutics, Inc.
 Kriya Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kriya Therapeutics, Inc. designs and develops transformative new treatments for prevalent and severe chronic diseases. The company was founded by Shankar Ramaswamy and Roger Jeffs and is headquartered in Redwood City, CA. | Founder | 01.01.2019 |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Director/Board Member | - |
Bull City Select Investments LLC
 Bull City Select Investments LLC Financial ConglomeratesFinance Bull City Select Investments LLC provides investment services. The private company is based in Research Triangle Park, NC. The company was founded by Roger A. Jeffs. | Founder | - |
Ehemalige bekannte Positionen von Roger Jeffs
| Unternehmen | Position | Ende |
|---|---|---|
| ALBIREO PHARMA, INC. | Director/Board Member | 03.01.2022 |
Evecxia, Inc.
 Evecxia, Inc. Miscellaneous Commercial ServicesCommercial Services Evecxia, Inc. is engaged in biotechnology services. The company was founded by Jacob Jacobsen and Marc Caron and is headquartered in Research Triangle Park, NC. | Director/Board Member | 02.03.2021 |
RareGen LLC
 RareGen LLC Miscellaneous Commercial ServicesCommercial Services RareGen LLC provides strategy, investment, and commercialization for rare disease pharmaceutical products. The company is headquartered in Durham, NC. | Director/Board Member | 01.11.2020 |
| DOVA PHARMACEUTICALS, INC. | Director/Board Member | 12.11.2019 |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Roger Jeffs
| Duke University | Undergraduate Degree |
| UNC School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| AXSOME THERAPEUTICS, INC. | Health Technology |
| LIQUIDIA CORPORATION | Health Technology |
| Private Unternehmen | 11 |
|---|---|
Spyryx Biosciences, Inc.
 Spyryx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Spyryx Biosciences, Inc. develops therapeutics for obstructive lung diseases with a particular focus on Cystic Fibrosis and chronic obstructive pulmonary disease. The company was founded by Robert Tarran in 2013 and is headquartered in Durham, NC. | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Health Technology |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
Bull City Select Investments LLC
Bull City Select Investments LLC Financial ConglomeratesFinance Bull City Select Investments LLC provides investment services. The private company is based in Research Triangle Park, NC. The company was founded by Roger A. Jeffs. | Finance |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
Evecxia, Inc.
Evecxia, Inc. Miscellaneous Commercial ServicesCommercial Services Evecxia, Inc. is engaged in biotechnology services. The company was founded by Jacob Jacobsen and Marc Caron and is headquartered in Research Triangle Park, NC. | Commercial Services |
Kriya Therapeutics, Inc.
Kriya Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kriya Therapeutics, Inc. designs and develops transformative new treatments for prevalent and severe chronic diseases. The company was founded by Shankar Ramaswamy and Roger Jeffs and is headquartered in Redwood City, CA. | Commercial Services |
RareGen LLC
RareGen LLC Miscellaneous Commercial ServicesCommercial Services RareGen LLC provides strategy, investment, and commercialization for rare disease pharmaceutical products. The company is headquartered in Durham, NC. | Commercial Services |
